HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Wuxi Biologics (2269 HK) - A Monopoly in China Macromolecule CDMO

Bloomage Biotechnology (688363.CH) - Accelerated Growth with the Approval of New Regulation

Pre-IPO Basecare Medical - Here Are the the Strengths and Concerns

Chongqing Zhifei Biological Products- Promising Future After Successful Renewal of Contract with MSD

Presentation for Webinar: 2021 High Conviction-Investment Opportunities in China Healthcare Industry

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Bottom-Up

Hygeia Healthcare Group / Equity Bottom-Up

<p>The number of cancer patients in China continues to grow, which brings huge market demand and promotes the rapid development of the oncology medical service market. With the support of policies, private hospitals have grown rapidly in recent years. With a strong network of oncology hospitals and radiotherapy centers, as well as a highly qualified medical team, <a href="https://www.smartkarma.com/entities/hygeia-healthcare-group" target="_blank" data-smartkarma-citation="entities:28875:1" rel="noopener">Hygeia Healthcare Group (6078 HK)</a> has become a leader in the field of oncology medical services. At the same time, the standardized operation and management mode enables the Company to continue to expand rapidly, and is expected to continue to maintain a leading edge in the future development. </p>

The number of cancer patients in China continues to grow, which brings huge market demand and promotes the rapid development of the oncology medical service market. With the support of policies, private hospitals have grown rapidly in recent years. With a strong network of oncology hospitals and radiotherapy centers, as well as a highly qualified medical team, Hygeia Healthcare Group (6078 HK) has become a leader in the field of oncology medical services. At the same time, the standardized operation and management mode enables the Company to continue to expand rapidly, and is expected to continue to maintain a leading edge in the future development. 

Hygeia Healthcare Group (6078 HK) - Good Business Model with Large Market Potential